Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
Brazilian chronic myeloid leukemia working group recommendations for discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia in clinical practice
Carla Boquimpani; Fernanda Salles Seguro; Gustavo Henrique Romani Magalhães; Ingrid Luise Soares Pinto; Israel Bendit; Jaisson André Pagnoncelli Bortolini; Katia Borgia Barbosa Pagnano; Renato Centrone; Vaneuza Funke;
Hematol Transfus Cell Ther. 2022;44:402-9
Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia
Arthur Gomes Oliveira Braga; Katia Borgia Barbosa Pagnano; Marina Dal'Bó Pelegrini Campioni; Ana Beatriz Pascoal Lopes; Gislaine Oliveira Duarte; Konradin Metze; Irene Lorand-Metze;
Hematol Transfus Cell Ther. 2024;46:268-72
An interesting case of chronic myeloid leukemia with twists and turns
Thulasi Raman Ramalingam; J. Subramanian; I. Nagarathinam; C. Chandran; L. Vaidhyanathan; J.M. Easow;
Hematol Transfus Cell Ther. 2024;46 Supl 6:S385-8